Libra Therapeutics
Latest round
- Series A
Last raised
- Sep 2020
Total raised
- $29M
Investors
- 6
About Libra Therapeutics
Founded in 2019 and headquartered in San Diego, US, Libra Therapeutics specializes in innovative therapies targeting lysosomal function.Libra Therapeutics develops innovative therapeutics aimed at improving lysosomal function to combat neurodegeneration associated with diseases like amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, and Parkinson’s disease. Their core offerings focus on small molecule-targeted mechanisms that enhance the body's ability to degrade and eliminate toxic proteins and dysfunctional organelles, addressing the underlying dysfunction characterizing these conditions.Information regarding the revenue structure of Libra Therapeutics is not publicly available. The company operates a business-to-business (B2B) model, engaging in partnerships with pharmaceutical companies and academic institutions for drug development. The company is focused on launching new products that enhance lysosomal function, with plans to target additional markets in Europe and North America by the end of 2022.
Who invested in Libra Therapeutics
6 investors across 1 round
See all investors in Libra Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 23, 2020
Amount
$29M
Investors
Questions about Libra Therapeutics
Who invested in Libra Therapeutics?
Libra Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Libra Therapeutics raised?
Libra Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Libra Therapeutics last raise money?
Libra Therapeutics's most recent round on record is a Series A, in Sep 2020.
What does Libra Therapeutics do?
Founded in 2019 and headquartered in San Diego, US, Libra Therapeutics specializes in innovative therapies targeting lysosomal function.
Where is Libra Therapeutics headquartered?
Libra Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Libra Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Libra Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Libra Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.